Global 3D Bioprinting Market is expected to reach XX Million by 2026 from 647.62 Million in 2019 at CAGR of XX %. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. Three dimensional (3D) bioprinting is the utilization of 3D printing–like techniques to combine cells, growth factors, and biomaterials to fabricate biomedical parts that maximally imitate natural tissue characteristics. Generally, 3D bioprinting utilizes the layer-by-layer method to deposit materials known as bioinks to create tissue-like structures that are later used in medical and tissue engineering fields. Bioprinting covers a broad range of biomaterials. Currently, bioprinting can be used to print tissues and organs to help research drugs and pills. However, emerging innovations span from bioprinting of cells or extracellular matrix deposited into a 3D gel layer by layer to produce the desired tissue or organ. In addition, 3D bioprinting has begun to incorporate the printing of scaffolds. These scaffolds can be used to regenerate joints and ligaments. Considering the need of such technology this market is blooming in industry. Many types of methods are used in bio printing for example, an infant patient with a rare respiratory disease known as Tracheobronchomalacia (TBM) was given a tracheal splint that was created with 3D printing . 3D bioprinting can be used to reconstruct tissue from various regions of the body, which is most attractive part of 3d printing, which is driving the market. Patients with end-stage bladder disease can be treated by using engineered bladder tissues to rebuild the damaged organ.This technology can also potentially be applied to bone, skin, cartilage and muscle tissue. Though there are several examples of tissue engineering using 3D bioprinting technology and very popular in growing market. Global 3D Bioprinting Market is segmented by technology type, material type, application, and geography. The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. The use of 3D Bioprinting is expected to capture the larger market in the near future. The growing demand for an organ transplant, research and development and the use in new drug discovery are major factors in its growth. This growth is attributed to increased efficiency. Increasing Customer Preference for Global 3D Bioprinting Market is trending the overall Global 3D Bioprinting Market. However, Lack of regulatory guidelines governing 3D Bioprinting will restrain the market growth. APAC is going to emerge as one of the higher growth regions during the forecast period followed by North America and Europe. Key Highlights: • Assessment of market definition along with the identification of key players and analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints and challenges for Global 3D Bioprinting Market during the forecast period • Complete quantitative analysis of the industry from 2017 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities • In-depth analysis of the industry on the basis of market segments, market dynamics, market size, competition & companies involved value chain • Global 3D Bioprinting Market analysis and comprehensive segmentation with respect to the technology type, material type, application and by geography to assist in strategic business planning. • Global 3D Bioprinting Market analysis and forecast for five major geographies North America, Europe, Asia Pacific, Middle East & Africa, Latin America and their key regions Years that have been considered for the study are as follows: • Base Year - 2018 • Estimated Year - 2019 • Forecast Period - 2019 to 2026 For company profiles, 2018 has been considered as the base year. In cases, wherein information was unavailable for the base year, the years prior to it have been considered Research Methodology: The objective of the report is to present comprehensive assessment projections with a suitable set of assumptions and methodology. The report helps in understanding Global 3D Bioprinting Market dynamics, structure by identifying and analyzing the market segments and projecting the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, growth strategies, and regional presence. To understand the market dynamics and by region, the report has covered the PEST analysis by region and key economies across the globe, which are supposed to have an impact on market in forecast period. PORTER’s analysis, and SVOR analysis of the market as well as detailed SWOT analysis of key players has been done to analyze their strategies. The report will to address all questions of shareholders to prioritize the efforts and investment in the near future to the emerging segment in the Global 3D Bioprinting Market. Key Players in the Global 3D Bioprinting Market Are: • Organovo Holdings, Inc. • Envisiontec Gmbh • 3Dynamic Systems Ltd. • Regenovo Biotechnology • Nano 3D Biosciences Ltd. • Cyfuse Biosciences K.K. • Poietis • Gesim • Regenhu Ltd. • Aspect Biosystems Ltd. • Biobots • Cellink • regenHU • Rainbow Biosciences • TeVido BioDevices • GeSiM Key Target Audience: • Research and Consulting Firms as well as Venture capitalists, private equity firms, and startup companies • 3D bioprinter manufacturers, suppliers, and distributors • Pharmaceutical and biotechnology companies • Healthcare institutions • Clinical research centers • Academic medical centers and universities • Business research and consulting firms • Government and regulatory authorities The scope of the Report: Research report categorizes Global 3D Bioprinting Market-based technology type, material type, application and by geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global 3D Bioprinting Market with key developments in companies and market trends. Global 3D Bioprinting Market, By Technology: • Magnetic 3D • Laser-Assisted • Inkjet 3D • Microextrision Global 3D Bioprinting Market, By Material Type: • Hydrogels • Extracellular Matrices • Living cells • Other Biomaterials Global 3D Bioprinting Market, By Application: • Clinical • Research Global 3D Bioprinting Market by Geography: • North America a) USA b) Canada • Asia Pacific a) China b) Japan c) South Korea d) Australia e) India f) Rest Of APAC • Europe a) UK b) Germany c) France d) Italy e) Sweden f) Spain g) Russia h) Rest Of Europe • Middle East and Africa a) Brazil b) Argentina c) Rest Of the Middle East and Africa • Latin America a) Brazil b) Argentina c) Rest Of Latin America Available Customization: Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client.
Table of Contents
1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET DYNAMICS 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. END-USER OVERVIEW 4.1. Value Chain Analysis 4.2.GLOBAL 3D BIOPRINTING MARKET Industry Trends and Emerging Technologies 5. GLOBAL 3D BIOPRINTING MARKET, BY TECHNOLOGY (2019-2026) 5.1. Introduction 5.2. Magnetic 3D 5.2.1. Magnetic 3D Market Overview 5.2.2. Magnetic 3D Size & Forecast 5.3. Laser-Assisted 5.3.1. Laser-Assisted Market Overview 5.3.2. Laser-Assisted Market Size & Forecast 5.4. Inkjet 3D 5.4.1. Inkjet 3D Market Overview 5.4.2. Inkjet 3D Size & Forecast 5.5. Microextrision 5.5.1. Microextrision Market Overview 5.5.2. Microextrision Market Size & Forecast 6. GLOBAL 3D BIOPRINTING MARKET, BY MATERIAL TYPE (2019-2026) 6.1. Introduction 6.2. Hydrogels 6.2.1. Hydrogels Market Overview 6.2.2. Hydrogels Market Size & Forecast 6.3. Extracellular Matrices 6.3.1. Extracellular Matrices Market Overview 6.3.2. Extracellular Matrices Size & Forecast 6.4. Living cells 6.4.1. Living cells Market Overview 6.4.2. Living cells Market Size & Forecast 6.5. Other Biomaterials 6.5.1. Other Biomaterials Market Overview 6.5.2. Other Biomaterials Market Size & Forecast 7. GLOBAL 3D BIOPRINTING MARKET, BY APPLICATION (2019-2026) 7.1. Introduction 7.2. Clinical 7.2.1. Clinical Market Overview 7.2.2. Clinical Market Size & Forecast 7.3. Research 7.3.1. Research Market Overview 7.3.2. Research Market Size & Forecast 8. GLOBAL 3D BIOPRINTING MARKET, BY GEOGRAPHY (2019-2026) 8.1. North America Global 3D Bioprinting Market 8.1.1. North America Global 3D Bioprinting Market, by Technology 8.1.2. North America Global 3D Bioprinting Market, by Market Material 8.1.3. North America Global 3D Bioprinting Market, by Application 188.8.131.52. U.S. Global 3D Bioprinting Market 184.108.40.206. Canada Global 3D Bioprinting Market 8.2. Europe Global 3D Bioprinting Market 8.2.1. Europe Global 3D Bioprinting Market, by Technology 8.2.2. Europe Global 3D Bioprinting Market, by Market Material 8.2.3. Europe Global 3D Bioprinting Market, by Application 8.2.4. Europe Global 3D Bioprinting Market, by Region 220.127.116.11. France Global 3D Bioprinting Market 18.104.22.168. Germany Global 3D Bioprinting Market 22.214.171.124. U.K .Global 3D Bioprinting Market 126.96.36.199. Italy Global 3D Bioprinting Market 188.8.131.52. Spain Global 3D Bioprinting Market 184.108.40.206. Sweden Global 3D Bioprinting Market 220.127.116.11. Russia Global 3D Bioprinting Market 18.104.22.168. Rest of Europe Global 3D Bioprinting Market 8.3. Asia Pacific Global 3D Bioprinting Market 8.3.1. Asia Pacific Global 3D Bioprinting Market, by Technology 8.3.2. Asia Pacific Global 3D Bioprinting Market, by Market Material 8.3.3. Asia-Pacific Global 3D Bioprinting Market, by Application 8.3.4. Asia-Pacific Global 3D Bioprinting Market, by Region 22.214.171.124. China Global 3D Bioprinting Market 126.96.36.199. Japan Global 3D Bioprinting Market 188.8.131.52. India Global 3D Bioprinting Market 184.108.40.206. South Korea Global 3D Bioprinting Market 220.127.116.11. Australia Global 3D Bioprinting Market 18.104.22.168. Rest of Asia Pacific Global 3D Bioprinting Market 8.4. Middle East & Africa Global 3D Bioprinting Market 8.4.1. Middle East & Africa Global 3D Bioprinting Market, by Technology 8.4.2. Middle East & Africa Global 3D Bioprinting Market, by Market Material 8.4.3. Middle East & Africa Global 3D Bioprinting Market, by Application 8.4.4. Middle East & Africa Global 3D Bioprinting Market, by Region 22.214.171.124. Brazil Global 3D Bioprinting Market 126.96.36.199. Argentina Global 3D Bioprinting Market 188.8.131.52. Rest of Middle East and Africa Global 3D Bioprinting Market 8.5. Latin America Global 3D Bioprinting Market 8.5.1. Latin America Global 3D Bioprinting Market, by Technology 8.5.2. Latin America Global 3D Bioprinting Market, by Market Material 8.5.3. Latin America Global 3D Bioprinting Market, by Application 8.5.4. Latin America Global 3D Bioprinting Market, by Region 184.108.40.206. Brazil Global 3D Bioprinting Market 220.127.116.11. Argentina Global 3D Bioprinting Market 18.104.22.168. Rest of Latin America Global 3D Bioprinting Market 9. MARKET COMPETITION ANALYSIS 9.1 Market Share/Positioning Analysis 9.2 Key Innovators 9.3 Company Profiles 9.3.1 Organovo Holdings, Inc. 22.214.171.124 Overview 126.96.36.199 Products/ End-User 188.8.131.52 Strategy 184.108.40.206 Key Developments 9.3.2 Envisiontec Gmbh 220.127.116.11 Overview 18.104.22.168 Products/ End-User 22.214.171.124 Strategy 126.96.36.199 Key Developments 9.3.3 3Dynamic Systems Ltd. 188.8.131.52 Overview 184.108.40.206 Products/ End-User 220.127.116.11 Strategy 18.104.22.168 Key Developments 9.3.4 Regenovo Biotechnology 22.214.171.124 Overview 126.96.36.199 Products/ End-User 188.8.131.52 Strategy 184.108.40.206 Key Developments 9.3.5 Nano 3D Biosciences Ltd. 220.127.116.11 Overview 18.104.22.168 Products/ End-User 22.214.171.124 Strategy 126.96.36.199 Key Developments 9.3.6 Cyfuse Biosciences K.K. 188.8.131.52 Overview 184.108.40.206 Products/ End-User 220.127.116.11 Strategy 18.104.22.168 Key Developments 9.3.7 Poietis 22.214.171.124 Overview 126.96.36.199 Products/ End-User 188.8.131.52 Strategy 184.108.40.206 Key Developments 9.3.8 Gesim 220.127.116.11 Overview 18.104.22.168 Products/ End-User 22.214.171.124 Strategy 126.96.36.199 Key Developments 9.3.9 Regenhu Ltd. 188.8.131.52 Overview 184.108.40.206 Products/ End-User 220.127.116.11 Strategy 18.104.22.168 Key Developments 9.3.10 Aspect Biosystems Ltd. 22.214.171.124 Overview 126.96.36.199 Products/ End-User 188.8.131.52 Strategy 184.108.40.206 Key Developments 9.3.11 Biobots 220.127.116.11 Overview 18.104.22.168 Products/ End-User 22.214.171.124 Strategy 126.96.36.199 Key Developments 9.3.12 Cellink 188.8.131.52 Overview 184.108.40.206 Products/ End-User 220.127.116.11 Strategy 18.104.22.168 Key Developments 9.3.13 Aisin Seiki Co. Ltd. 22.214.171.124 Overview 126.96.36.199 Products/ End-User 188.8.131.52 Strategy 184.108.40.206 Key Developments 9.3.14 regenHU 220.127.116.11 Overview 18.104.22.168 Products/ End-User 22.214.171.124 Strategy 126.96.36.199 Key Developments 9.3.15 Rainbow Biosciences 188.8.131.52 Overview 184.108.40.206 Products/ End-User 220.127.116.11 Strategy 18.104.22.168 Key Developments 9.3.16 TeVido BioDevices 22.214.171.124 Overview 126.96.36.199 Products/ End-User 188.8.131.52 Strategy 184.108.40.206 Key Developments 9.3.17 GeSiM 220.127.116.11 Overview 18.104.22.168 Products/ End-User 22.214.171.124 Strategy 126.96.36.199 Key Developments